Aibotics Inc. (AIBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
-0.0010 (-50.00%)
Apr 29, 2026, 3:53 PM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $906.92 thousand as of April 29, 2026. Its market cap has increased by 373.07% in one year.
Market Cap
906.92K
Enterprise Value
1.93M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 906.92K, a decrease of -97.84%. That is a compound annual growth rate of -51.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 906.92K | -25.49% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EV Biologics | 511.27K |
| Altamira Therapeutics | 513.82K |
| Bio-Path Holdings | 521.76K |
| Sorrento Therapeutics | 489.34K |
| Hepion Pharmaceuticals | 476.43K |
| Regenerative Medical Technology Group | 463.81K |
| CNBX Pharmaceuticals | 429.02K |
| Emmaus Life Sciences | 624.68K |